Overview

Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition

Status:
Completed
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This trial investigates effects of a glucagon bolus injection on heart rate, blood pressure and cardiac output during beta-blocker-induced cardiodepression. Furthermore, the effects of two different doses of intravenous glucagon on hemodynamic parameters are explored.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Bispebjerg and Frederiksberg
Treatments:
Adrenergic beta-Antagonists
Esmolol
Glucagon
Glucagon-Like Peptide 1
Pharmaceutical Solutions